Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Thorat, Dhanaji Achyutrao | - |
dc.contributor.author | Doddareddy, Munikumar Reddy | - |
dc.contributor.author | Seo, Seon Hee | - |
dc.contributor.author | Hong, Tae-Joon | - |
dc.contributor.author | Cho, Yong Seo | - |
dc.contributor.author | Hahn, Ji-Sook | - |
dc.contributor.author | Pae, Ae Nim | - |
dc.date.accessioned | 2024-01-20T17:31:17Z | - |
dc.date.available | 2024-01-20T17:31:17Z | - |
dc.date.created | 2021-09-02 | - |
dc.date.issued | 2011-03-15 | - |
dc.identifier.issn | 0960-894X | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/130536 | - |
dc.description.abstract | Novel 2,4-diaminoquinazoline derivatives originating from a virtual screening approach were designed, synthesized and their biological activities as heat shock protein 90 (Hsp90) inhibitors were evaluated. The prepared compounds exhibited significant anti-proliferative activities against DU-145, HT-29, HCT-116, A375P and MCF-7 cancer cell lines. The selected compounds were tested against Her2, a client protein of Hsp90, and showed significant reduction in Her2 protein expression. Compound 6b was found the most potent, reduced Her2 protein expression levels and induced Hsp70 protein expression levels significantly. (C) 2011 Elsevier Ltd. All rights reserved. | - |
dc.language | English | - |
dc.publisher | Pergamon Press Ltd. | - |
dc.subject | NUCLEOTIDE-SEQUENCE | - |
dc.subject | THERAPEUTIC TARGET | - |
dc.subject | HSP90 | - |
dc.subject | CHAPERONE | - |
dc.subject | STRESS | - |
dc.subject | COMPLEX | - |
dc.subject | CDNA | - |
dc.title | Synthesis and biological evaluation of 2,4-diaminoquinazoline derivatives as novel heat shock protein 90 inhibitors | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.bmcl.2011.01.117 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | Bioorganic & Medicinal Chemistry Letters, v.21, no.6, pp.1593 - 1597 | - |
dc.citation.title | Bioorganic & Medicinal Chemistry Letters | - |
dc.citation.volume | 21 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 1593 | - |
dc.citation.endPage | 1597 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.wosid | 000288012800004 | - |
dc.identifier.scopusid | 2-s2.0-79952364637 | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | NUCLEOTIDE-SEQUENCE | - |
dc.subject.keywordPlus | THERAPEUTIC TARGET | - |
dc.subject.keywordPlus | HSP90 | - |
dc.subject.keywordPlus | CHAPERONE | - |
dc.subject.keywordPlus | STRESS | - |
dc.subject.keywordPlus | COMPLEX | - |
dc.subject.keywordPlus | CDNA | - |
dc.subject.keywordAuthor | Hsp90 inhibitors | - |
dc.subject.keywordAuthor | Cancer | - |
dc.subject.keywordAuthor | 2,4-Diaminoquinazolines | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.